CHRISTOPHE JEAN

Insider Reports History

Location
Paris, France
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Christophe Jean
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHRISTOPHE JEAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
RHYTHM PHARMACEUTICALS, INC. Director Common Stock 7,000 $421,260 $60.18 18 Jun 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Restricted Stock Units 4,712 $0 $39.10 24 Jun 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 7,037 24 Jun 2025 Direct

Insider Reports Filed by CHRISTOPHE JEAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RYTM RHYTHM PHARMACEUTICALS, INC. 24 Jun 2025 2 $0 4 Director 26 Jun 2025, 16:41
RYTM RHYTHM PHARMACEUTICALS, INC. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 16:53
RYTM RHYTHM PHARMACEUTICALS, INC. 21 Jun 2024 2 $0 4 Director 25 Jun 2024, 16:35
RYTM RHYTHM PHARMACEUTICALS, INC. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 21:42
RYTM RHYTHM PHARMACEUTICALS, INC. 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 16:31
RYTM RHYTHM PHARMACEUTICALS, INC. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:06
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:06